{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T16:55:07Z","timestamp":1744217707629},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T00:00:00Z","timestamp":1650153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T00:00:00Z","timestamp":1650153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00415-022-11113-y","type":"journal-article","created":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T05:02:27Z","timestamp":1650171747000},"page":"4783-4790","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Spinal cord sarcoidosis in Japan: utility of cerebrospinal fluid examination and nerve conduction study for diagnosis and prognosis prediction"],"prefix":"10.1007","volume":"269","author":[{"given":"Miwako","family":"Fujisawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiaki","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,17]]},"reference":[{"key":"11113_CR1","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","volume":"383","author":"D Valeyre","year":"2014","unstructured":"Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, M\u00fcller-Quernheim J (2014) Sarcoidosis. Lancet 383:1155\u20131167. https:\/\/doi.org\/10.1016\/S0140-6736(13)60680-7","journal-title":"Lancet"},{"key":"11113_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S1474-4422(04)00805-1","volume":"3","author":"E Hoitsma","year":"2004","unstructured":"Hoitsma E, Faber CG, Drent M, Sharma OP (2004) Neurosarcoidosis: a clinical dilemma. Lancet Neurol 3:397\u2013407. https:\/\/doi.org\/10.1016\/S1474-4422(04)00805-1","journal-title":"Lancet Neurol"},{"key":"11113_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/qjmed\/92.2.103","volume":"92","author":"JP Zajicek","year":"1999","unstructured":"Zajicek JP, Scolding NJ, Foster O et al (1999) Central nervous system sarcoidosis\u2013diagnosis and management. QJM 92:103\u2013117. https:\/\/doi.org\/10.1093\/qjmed\/92.2.103","journal-title":"QJM"},{"key":"11113_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4081\/reumatismo.2017.965","volume":"69","author":"P Ungprasert","year":"2017","unstructured":"Ungprasert P, Crowson CS, Matteson EL (2017) Epidemiology and clinical characteristics of sarcoidosis: an update from a population-based cohort study from Olmsted County, Minnesota. Reumatismo 69:16\u201322. https:\/\/doi.org\/10.4081\/reumatismo.2017.965","journal-title":"Reumatismo"},{"key":"11113_CR5","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1513\/AnnalsATS.201511-760OC","volume":"13","author":"RP Baughman","year":"2016","unstructured":"Baughman RP, Field S, Costabel U, Crystal RG, Culver DA, Drent M, Judson MA, Wolff G (2016) Sarcoidosis in America: analysis based on health care use. Ann Am Thorac Soc 13:1244\u20131252. https:\/\/doi.org\/10.1513\/AnnalsATS.201511-760OC","journal-title":"Ann Am Thorac Soc"},{"key":"11113_CR6","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1183\/09031936.00075307","volume":"31","author":"T Morimoto","year":"2008","unstructured":"Morimoto T, Azuma A, Abe S, Usuki J, Kudoh S, Sugisaki K, Oritsu M, Nukiwa T (2008) Epidemiology of sarcoidosis in Japan. Eur Respir J 31:372\u2013379. https:\/\/doi.org\/10.1183\/09031936.00075307","journal-title":"Eur Respir J"},{"key":"11113_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.resinv.2019.11.003","volume":"58","author":"Y Yamanouchi","year":"2020","unstructured":"Yamanouchi Y, Sawahata M, Sakamoto N et al (2020) Characteristics of 68 patients with clinically proven sarcoidosis based on the Japan Society of Sarcoidosis and Other Granulomatous Disorders 2015 criteria. Respir Investig 58:102\u2013109. https:\/\/doi.org\/10.1016\/j.resinv.2019.11.003","journal-title":"Respir Investig"},{"key":"11113_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.rmed.2014.12.012","volume":"109","author":"M Sawahata","year":"2015","unstructured":"Sawahata M, Sugiyama Y, Nakamura Y, Nakayama M, Mato N, Yamasawa H, Bando M (2015) Age-related and historical changes in the clinical characteristics of sarcoidosis in Japan. Respir Med 109:272\u2013278. https:\/\/doi.org\/10.1016\/j.rmed.2014.12.012","journal-title":"Respir Med"},{"key":"11113_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/BF01405845","volume":"65","author":"J Bogousslavsky","year":"1982","unstructured":"Bogousslavsky J, Hungerb\u00fchler JP, Regli F, Graf HJ (1982) Subacute myelopathy as the presenting manifestation of sarcoidosis. Acta Neurochir 65:193\u2013197. https:\/\/doi.org\/10.1007\/BF01405845","journal-title":"Acta Neurochir"},{"key":"11113_CR10","first-page":"1052","volume":"37","author":"P Brito-Zer\u00f3n","year":"2019","unstructured":"Brito-Zer\u00f3n P, Kostov B, Superville D, Baughman RP, Ramos-Casals M, Autoimmune Big Data Study Group (2019) Geoepidemiological big data approach to sarcoidosis: geographical and ethnic determinants. Clin Exp Rheumatol 37:1052\u20131064","journal-title":"Clin Exp Rheumatol"},{"key":"11113_CR11","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0929-6646(09)60117-0","volume":"105","author":"CW Hsieh","year":"2006","unstructured":"Hsieh CW, Chen DY, Lan JL (2006) Late-onset and rare far-advanced pulmonary involvement in patients with sarcoidosis in Taiwan. J Formos Med Assoc 105:269\u2013276. https:\/\/doi.org\/10.1016\/S0929-6646(09)60117-0","journal-title":"J Formos Med Assoc"},{"key":"11113_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.36141\/svdld.v34i3.5727","volume":"34","author":"Z Ying","year":"2017","unstructured":"Ying Z, Elyse EL, Yinping F, Shanshan D, Huiping L, Robert PB (2017) Clinical characteristics of sarcoidosis patients in the United States versus China. Sarcoidosis Vasc Diffuse Lung Dis 34:209\u2013216. https:\/\/doi.org\/10.36141\/svdld.v34i3.5727","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"11113_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/MD.0b013e3181d5c6b4","volume":"89","author":"F Cohen-Aubart","year":"2010","unstructured":"Cohen-Aubart F, Galanaud D, Grabli D et al (2010) Spinal cord sarcoidosis: clinical and laboratory profile and outcome of 31 patients in a case-control study. Medicine 89:133\u2013140. https:\/\/doi.org\/10.1097\/MD.0b013e3181d5c6b4","journal-title":"Medicine"},{"key":"11113_CR14","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00415-016-8092-5","volume":"263","author":"CA Durel","year":"2016","unstructured":"Durel CA, Marignier R, Maucort-Boulch D et al (2016) Clinical features and prognostic factors of spinal cord sarcoidosis: a multicenter observational study of 20 biopsy-proven patients. J Neurol 263:981\u2013990. https:\/\/doi.org\/10.1007\/s00415-016-8092-5","journal-title":"J Neurol"},{"key":"11113_CR15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1212\/wnl.43.2.333","volume":"43","author":"SS Junger","year":"1993","unstructured":"Junger SS, Stern BJ, Levine SR, Sipos E, Marti-Masso JF (1993) Intramedullary spinal sarcoidosis: clinical and magnetic resonance imaging characteristics. Neurology 43:333\u2013337. https:\/\/doi.org\/10.1212\/wnl.43.2.333","journal-title":"Neurology"},{"key":"11113_CR16","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/s0090-3019(96)00440-5","volume":"48","author":"GI Jallo","year":"1997","unstructured":"Jallo GI, Zagzag D, Lee M, Deletis V, Morota N, Epstein FJ (1997) Intraspinal sarcoidosis: diagnosis and management. Surg Neurol 48:514\u2013520. https:\/\/doi.org\/10.1016\/s0090-3019(96)00440-5","journal-title":"Surg Neurol"},{"key":"11113_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1468-1331.2008.02409.x","volume":"16","author":"L Varron","year":"2009","unstructured":"Varron L, Broussolle C, Candessanche JP, Marignier R, Rousset H, Ninet J, S\u00e8ve P (2009) Spinal cord sarcoidosis: report of seven cases. Eur J Neurol 16:289\u2013296. https:\/\/doi.org\/10.1111\/j.1468-1331.2008.02409.x","journal-title":"Eur J Neurol"},{"key":"11113_CR18","first-page":"965","volume":"98","author":"S Saleh","year":"2006","unstructured":"Saleh S, Saw C, Marzouk K, Sharma O (2006) Sarcoidosis of the spinal cord: literature review and report of eight cases. J Natl Med Assoc 98:965\u2013976","journal-title":"J Natl Med Assoc"},{"key":"11113_CR19","first-page":"58","volume":"23","author":"DA Bradley","year":"2006","unstructured":"Bradley DA, Lower EE, Baughman RP (2006) Diagnosis and management of spinal cord sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 23:58\u201365","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"11113_CR20","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s004150070154","volume":"247","author":"H Koike","year":"2000","unstructured":"Koike H, Misu K, Yasui K, Kameyama T, Ando T, Yanagi T, Sobue G (2000) Differential response to corticosteroid therapy of MRI findings and clinical manifestations in spinal cord sarcoidosis. J Neurol 247:544\u2013549. https:\/\/doi.org\/10.1007\/s004150070154","journal-title":"J Neurol"},{"key":"11113_CR21","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1007\/s00415-011-6080-3","volume":"258","author":"K Sakushima","year":"2011","unstructured":"Sakushima K, Yabe I, Nakano F, Yoshida K, Tajima Y, Houzen H, Maruo Y, Sasaki H (2011) Clinical features of spinal cord sarcoidosis: analysis of 17 neurosarcoidosis patients. J Neurol 258:2163\u20132167. https:\/\/doi.org\/10.1007\/s00415-011-6080-3","journal-title":"J Neurol"},{"key":"11113_CR22","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.2169\/internalmedicine.52.0186","volume":"52","author":"S Kobayashi","year":"2013","unstructured":"Kobayashi S, Nakata W, Sugimoto H (2013) Spinal magnetic resonance imaging manifestations at neurological onset in Japanese patients with spinal cord sarcoidosis. Intern Med 52:2041\u20132050. https:\/\/doi.org\/10.2169\/internalmedicine.52.0186","journal-title":"Intern Med"},{"key":"11113_CR23","doi-asserted-by":"publisher","first-page":"E1290","DOI":"10.1097\/BRS.0b013e3181e6d592","volume":"35","author":"Y Sakai","year":"2010","unstructured":"Sakai Y, Matsuyama Y, Imagama S et al (2010) Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Spine 35:E1290\u2013E1297. https:\/\/doi.org\/10.1097\/BRS.0b013e3181e6d592","journal-title":"Spine"},{"key":"11113_CR24","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s00586-009-0891-2","volume":"18","author":"K Oe","year":"2009","unstructured":"Oe K, Doita M, Miyamoto H, Kanda F, Kurosaka M, Sumi M (2009) Is extensive cervical laminoplasty an effective treatment for spinal cord sarcoidosis combined with cervical spondylosis? Eur Spine J 18:570\u2013576. https:\/\/doi.org\/10.1007\/s00586-009-0891-2","journal-title":"Eur Spine J"},{"key":"11113_CR25","unstructured":"The Japan Society of Sarcoidosis and Other Granulomatous Disorders. Diagnostic standard and guideline for sarcoidosis\u20142015. http:\/\/www.jssog.com\/www\/top\/shindan\/shindan2-1new.html [in Japanese]"},{"key":"11113_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jccase.2015.05.003","volume":"12","author":"N Moriyama","year":"2015","unstructured":"Moriyama N, Ohara T, Kanzaki H, Tsuda E, Ishihara M, Anzai T (2015) Active cardiac sarcoidosis in a patient with adult-onset Kawasaki disease. J Cardiol Cases 12:68\u201371. https:\/\/doi.org\/10.1016\/j.jccase.2015.05.003","journal-title":"J Cardiol Cases"},{"key":"11113_CR27","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.str.19.5.604","volume":"19","author":"JC van Swieten","year":"1988","unstructured":"van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604\u2013607. https:\/\/doi.org\/10.1161\/01.str.19.5.604","journal-title":"Stroke"},{"key":"11113_CR28","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/00019052-200406000-00013","volume":"17","author":"BJ Stern","year":"2004","unstructured":"Stern BJ (2004) Neurological complications of sarcoidosis. Curr Opin Neurol 17:311\u2013316. https:\/\/doi.org\/10.1097\/00019052-200406000-00013","journal-title":"Curr Opin Neurol"},{"key":"11113_CR29","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2174\/157015911796557975","volume":"9","author":"D Lacomis","year":"2011","unstructured":"Lacomis D (2011) Neurosarcoidosis. Curr Neuropharmacol 9:429\u2013436. https:\/\/doi.org\/10.2174\/157015911796557975","journal-title":"Curr Neuropharmacol"},{"key":"11113_CR30","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1212\/wnl.57.5.927","volume":"57","author":"D Ferriby","year":"2001","unstructured":"Ferriby D, de Seze J, Stojkovic T, Hachulla E, Wallaert B, Dest\u00e9e A, Hatron PY, Vermersch P (2001) Long-term follow-up of neurosarcoidosis. Neurology 57:927\u2013929. https:\/\/doi.org\/10.1212\/wnl.57.5.927","journal-title":"Neurology"},{"key":"11113_CR31","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1136\/jnnp.47.11.1219","volume":"47","author":"YB Challenor","year":"1984","unstructured":"Challenor YB, Felton CP, Brust JC (1984) Peripheral nerve involvement in sarcoidosis: an electrodiagnostic study. J Neurol Neurosurg Psychiatry 47:1219\u20131222. https:\/\/doi.org\/10.1136\/jnnp.47.11.1219","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11113_CR32","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1007\/s00415-010-5623-3","volume":"257","author":"HF Petereit","year":"2010","unstructured":"Petereit HF, Reske D, Tumani H, Jarius S, Markus Leweke F, Woitalla D, Pfister HW, Rubbert A (2010) Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosis. J Neurol 257:1855\u20131863. https:\/\/doi.org\/10.1007\/s00415-010-5623-3","journal-title":"J Neurol"},{"key":"11113_CR33","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000725","volume":"7","author":"C Otto","year":"2020","unstructured":"Otto C, Wengert O, Unterwalder N, Meisel C, Ruprecht K (2020) Analysis of soluble interleukin-2 receptor as CSF biomarker for neurosarcoidosis. Neurol Neuroimmunol Neuroinflamm 7:e725. https:\/\/doi.org\/10.1212\/NXI.0000000000000725","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"11113_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223897","volume":"14","author":"LEM Eurelings","year":"2019","unstructured":"Eurelings LEM, Miedema JR, Dalm VASH, van Daele PLA, van Hagen PM, van Laar JAM, Dik WA (2019) Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis. PLoS One 14:e0223897. https:\/\/doi.org\/10.1371\/journal.pone.0223897","journal-title":"PLoS One"},{"key":"11113_CR35","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1378\/chest.124.1.186","volume":"124","author":"JC Grutters","year":"2003","unstructured":"Grutters JC, Fellrath JM, Mulder L, Janssen R, van den Bosch JM, van Velzen-Blad H (2003) Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation. Chest 124:186\u2013195. https:\/\/doi.org\/10.1378\/chest.124.1.186","journal-title":"Chest"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11113-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11113-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11113-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T15:07:26Z","timestamp":1660057646000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11113-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,17]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["11113"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11113-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,17]]},"assertion":[{"value":"25 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors report no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the ethics committee of the Yamaguchi University Medical Faculty in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}